Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Equity (2020 - 2026)

Pliant Therapeutics has reported Return on Equity over the past 7 years, most recently at 0.01% for Q1 2026.

  • Quarterly Return on Equity changed 0.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.01% for Q1 2026 at Pliant Therapeutics, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q2 2023 and troughed at 0.01% in Q2 2025.
  • The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
  • The largest YoY upside for Return on Equity was 0bps in 2022 against a maximum downside of 0bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then rose by 13bps to 0.0% in 2023, then crashed by -96bps to 0.01% in 2024, then dropped by -19bps to 0.01% in 2025, then rose by 17bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Return on Equity are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).